who will be the priority people?



[ad_1]

There is now talk of potential vaccines against Covid-19. No deadline is yet known regarding their arrival on the market. But already the High Authority for Health (HAS) is working on the vaccine strategy implemented “during the year 2021”.

The two reasons that prioritize access to immunization are “the existence of an individual risk factor for the development of a severe form of the disease and increased exposure to the virus,” explains HAS.

The objective is twofold: “to reduce hospitalizations and deaths and to maintain the country’s essential activities, in particular those of the health system during the epidemic”.

As of today, it is too early to talk about eradicating SARS-CoV-2 through vaccination. “In order for the vaccine strategy to target epidemic control, it is necessary to wait for studies to establish evidence that vaccines have a possible effect on virus transmission and that vaccine availability is sufficient. “

Photo by the National Cancer Institute on Unsplash
Photo by the National Cancer Institute on Unsplash

In several stages

HAS recommends vaccination as a priority elderly residents in residential care facilities for the dependent elderly (EHPAD). Accounting for one third of deaths, they are the first victims of the disease.

Second step: vaccinating those over 75, then people aged 65 to 74 with a comorbid condition, then other people aged 65 to 74.

The HAS also recommends continuing vaccination of healthcare, medico-social and medical transport professionals.

Third phase: immunize over the age of 50 and those under 50 with “comorbidities (obesity (BMI> 30), COPD * and respiratory failure, complicated arterial hypertension, heart failure, type 1 and 2 diabetes, chronic renal failure, recent cancers under the age of three, transplantation of solid organs or hematopoietic stem cells and trisomy 21) “.

Fourth stage: vaccinate exposed professionals who would not have been yet (the youngest).

Last step:over 18 years old without comorbidities.

Note: These recommendations will be adapted according to the epidemiological situation and knowledge of the disease.

* chronic obstructive pulmonary disease

[ad_2]
Source link